Last updated: October 14, 2024
Sponsor: University of Pennsylvania
Overall Status: Completed
Phase
N/A
Condition
Atrial Fibrillation
Chest Pain
Cardiac Disease
Treatment
Standard Atrial fibrillation ablation
Coronary sinus to left atrium connection elimination
Clinical Study ID
NCT03646643
829990
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with paroxysmal or persistent atrial fibrillation; AND Undergoing first AFablation; AND Age ≥ 18 years.
Exclusion
Exclusion Criteria:
- Previous left atrial ablation; Women currently pregnant; Mental or physicalinability to take part in the study; Known terminally ill patients.
Study Design
Total Participants: 35
Treatment Group(s): 2
Primary Treatment: Standard Atrial fibrillation ablation
Phase:
Study Start date:
August 18, 2018
Estimated Completion Date:
September 22, 2021
Study Description
Connect with a study center
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.